Tower Research Capital LLC (TRC)
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in BTAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,302
-$7,766 QoQ
Shares Held
1,718
-56.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 40 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $6,300,576 across 59 Drug Manufacturers - Specialty & Generic names. BTAI ranks #54 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,684 | $998,578 | |
| 2 | ALKS |
Alkermes plc.
|
16,120 | $570,003 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
4,070 | $536,181 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
19,404 | $464,337 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
6,000 | $455,100 | |
| 6 | ZTS |
Zoetis Inc.
|
3,469 | $410,069 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
16,717 | $347,044 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
23,887 | $227,404 |
All Filings in BTAI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,302 | 1,718 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $10,068 | 3,933 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,479 | 1,370 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $308 | 152 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||